Tag: Ozempic

• Health & Wellness Risk Stock Market

  

  Novo Nordisk: Time to Sell?

  Novo Nordisk shareholders have grown fat even as the obesity drug company’s customers have been losing weight. From relative obscurity just five years ago, Novo Nordisk has become the most valuable company in Europe. The promise of future returns is built into the stock price. In this post, we look…

  January 9, 2024